DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo

Oncothyreon, Inc. (NASDAQ: ONTY)

1.72 -0.02 (-1.15%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ONTY $1.72 -1.15%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.75
Previous Close $1.74
Daily Range $1.69 - $1.75
52-Week Range $1.48 - $3.60
Market Cap $176.0M
P/E Ratio -2.72
Dividend (Yield) $0.00 (0.0%)
Volume 600,158
Average Daily Volume 822,529
Current FY EPS -$0.34

Sector

Healthcare

Industry

Drug Makers

Oncothyreon, Inc. (ONTY) Description

Oncothyreon Inc. is a clinical-stage biopharmaceutical company which is focused on the development of therapeutic products for the treatment of cancer. Website: http://www.oncothyreon.com/

News & Commentary Rss Feed

Why Oncotheryeon, Inc., OncoMed Pharmaceuticals, Inc., and Array BioPharma Inc. Stocks Jumped Today

Three biotechs climb after a competitor's trial success boosts hope across the HER-2 breast cancer treatment market

Celldex Therapeutics Pushes Forward With Varlilumab And Further Proves Its Worth

Oncothyreon (ONTY) Shares March Higher, Can It Continue? - Tale of the Tape

Oncothyreon (ONTY) Shares March Higher, Can It Continue? - Tale of the Tape

Oncothyreon Inc. (ONTY) in Focus: Stock Rises 6.3% - Tale of the Tape

Oncothyreon Inc. (ONTY) in Focus: Stock Rises 6.3% - Tale of the Tape

Benzinga's Top Initiations

Oncothyreon (ONTY) CEO Dr. Robert Kirkman on Q4 2014 Results - Earnings Call Transcript

UPDATE: Oncothyreon Shares Drop After Q4 Results

Oncothyreon Inc . (ONTY) Q4 2014 Results - Earnings Call Webcast

Should You Buy Oncothyreon Inc (ONTY) Ahead of Earnings? - Tale of the Tape

Weekly Analyst Highlights: Oil, Tesla On Readers' Minds

How Wall Street Is Reacting To The Pharmacyclics Rumor

See More ONTY News...

ONTY's Top Competitors

ONTY $1.72 (-1.15%)
Current stock: ONTY
AMGN $163.58 (-1.97%)
Current stock: AMGN
GILD $101.38 (-1.90%)
Current stock: GILD
BIIB $419.44 (-2.15%)
Current stock: BIIB